Show simple item record

dc.contributor.authorBrunelli, Alessandro
dc.contributor.authorCharloux, Anne
dc.contributor.authorBolliger, Chris T
dc.contributor.authorRocco, Gaetano
dc.contributor.authorSculier, Jean-Paul
dc.contributor.authorVarela, Gonzalo
dc.contributor.authorLicker, Marc
dc.contributor.authorFerguson, Mark K
dc.contributor.authorFaivre-Finn, Corinne
dc.contributor.authorHuber, Rudolf Maria
dc.contributor.authorClini, Enrico M
dc.contributor.authorWin, Thida
dc.contributor.authorDe Ruysscher, Dirk
dc.contributor.authorGoldman, Lee
dc.date.accessioned2009-11-05T11:44:11Z
dc.date.available2009-11-05T11:44:11Z
dc.date.issued2009-07
dc.identifier.citationThe European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer. 2009, 36 (1):181-4 Eur J Cardiothorac Surgen
dc.identifier.issn1873-734X
dc.identifier.pmid19477657
dc.identifier.doi10.1016/j.ejcts.2009.04.022
dc.identifier.urihttp://hdl.handle.net/10541/85386
dc.description.abstractThe European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS) established a joint task force with the purpose to develop clinical evidence-based guidelines on evaluation of fitness for radical therapy in patients with lung cancer. The following topics were discussed, and are summarized in the final report along with graded recommendations: Cardiologic evaluation before lung resection; lung function tests and exercise tests (limitations of ppoFEV1; DLCO: systematic or selective?; split function studies; exercise tests: systematic; low-tech exercise tests; cardiopulmonary (high tech) exercise tests); future trends in preoperative work-up; physiotherapy/rehabilitation and smoking cessation; scoring systems; advanced care management (ICU/HDU); quality of life in patients submitted to radical treatment; combined cancer surgery and lung volume reduction surgery; compromised parenchymal sparing resections and minimally invasive techniques: the balance between oncological radicality and functional reserve; neoadjuvant chemotherapy and complications; definitive chemo and radiotherapy: functional selection criteria and definition of risk; should surgical criteria be re-calibrated for radiotherapy?; the patient at prohibitive surgical risk: alternatives to surgery; who should treat thoracic patients and where these patients should be treated?
dc.language.isoenen
dc.subjectLung Canceren
dc.subject.meshAlgorithms
dc.subject.meshCombined Modality Therapy
dc.subject.meshEvidence-Based Medicine
dc.subject.meshExercise Test
dc.subject.meshHealth Status Indicators
dc.subject.meshHumans
dc.subject.meshLung Neoplasms
dc.subject.meshRespiratory Function Tests
dc.subject.meshRisk Assessment
dc.titleThe European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer.en
dc.typeArticleen
dc.contributor.departmentDivision of Thoracic Surgery, Umberto I Regional Hospital, Ancona, Italy. alexit_2000@yahoo.comen
dc.identifier.journalEuropean Journal of Cardio-Thoracic Surgeryen
html.description.abstractThe European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS) established a joint task force with the purpose to develop clinical evidence-based guidelines on evaluation of fitness for radical therapy in patients with lung cancer. The following topics were discussed, and are summarized in the final report along with graded recommendations: Cardiologic evaluation before lung resection; lung function tests and exercise tests (limitations of ppoFEV1; DLCO: systematic or selective?; split function studies; exercise tests: systematic; low-tech exercise tests; cardiopulmonary (high tech) exercise tests); future trends in preoperative work-up; physiotherapy/rehabilitation and smoking cessation; scoring systems; advanced care management (ICU/HDU); quality of life in patients submitted to radical treatment; combined cancer surgery and lung volume reduction surgery; compromised parenchymal sparing resections and minimally invasive techniques: the balance between oncological radicality and functional reserve; neoadjuvant chemotherapy and complications; definitive chemo and radiotherapy: functional selection criteria and definition of risk; should surgical criteria be re-calibrated for radiotherapy?; the patient at prohibitive surgical risk: alternatives to surgery; who should treat thoracic patients and where these patients should be treated?


Files in this item

This item appears in the following Collection(s)

Show simple item record